CD177 and neoplasm: When the KRASG12D protein is released and absorbed by macrophages via a specific cell surface receptor called RAGE (an advanced glycation end‐product), it induces fatty acid oxidation and promotes the conversion of macrophages into M2‐like tumor‐associated macrophages (TAMs) and activates the tumor‐promoting effect of macrophages.